Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1776112-90-3
Purity
95%
PF-06747775 (Mavelertinib) is an orally available, selective and potent EGFR tyrosine kinase inhibitor with inhibitory effects on T790M/L858R and T790M/Del.
Properties
Name
PF-06747775
Smiles
COC1=NN(C)C=C1NC=2N=C(N=C3N(C)C=NC23)N4C[C@@H](F)[C@@H](C4)NC(=O)C=C
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
PF-06747775 | mavelertinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$90
2 mg
$94
5 mg
$98
10 mg
$117
15 mg
$158
20 mg
$199
25 mg
$237
30 mg
$276
35 mg
$306
40 mg
$337
45 mg
$363
50 mg
$400
75 mg
$553
100 mg
$POA
Quantity
1
Total amount
$ 98
PF-06747775 | mavelertinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.